Search results
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 6 days agoS., David Daigle, a Centers...vaccines were accessible for uninsured and underinsured patients. ...
New Covid FLiRT Variants Have the FDA Weighing a Vaccine Update
Bloomberg· 5 days agoGood morning! It’s Jessica in New York. A new Covid variant is forcing the FDA to reevaluate...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 2 days agoModerna's mRNA vaccine platform proved its value in the coronavirus market. The company has many...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via AOL· 4 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 5 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 4 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider...follow blueprint for success, including guidance on building...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 5 days agoDue to the virus’s remarkable capacity for mutation and immune evasion, the World Health...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 5 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 6 days agoBy working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 6 days agoThe Stock Advisor service has more than quadrupled the return...The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends ...
